Emerging research suggest Retatrutide , a dual stimulator targeting both GLP-1 and GIP , could represent a promising step forward for weight loss . Early human trials have indicated considerable reductions in body fat , potentially surpassing current weight-loss medications . However , further assessment is necessary to completely understand its su